Sexually transmitted infections and migration in Uganda: a population-based study.

AFRICA HIV MIGRATION SYPHILIS

Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
12 Aug 2024
Historique:
received: 27 03 2024
accepted: 28 07 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 12 8 2024
Statut: aheadofprint

Résumé

Migration is associated with increased risk of HIV infection in Africa, but evidence about non-HIV sexually transmitted infection (STI) burden among African migrants is limited. We used data from the Sexually Transmitted Infection Prevalence Study, a cross-sectional population-based study of chlamydia, gonorrhoea, trichomoniasis, syphilis and herpes simplex virus type 2 prevalence in southern Uganda, to compare STI prevalence between adults aged 18 and 49 years with and without a recent history of migration. Migration status was determined using household census data, with a recent migration history defined as having moved into one's community of current residence within the last ~18 months. Unadjusted and adjusted modified Poisson regression models were used to compare individual STI prevalence risk by recent migration status with associations reported as adjusted prevalence risk ratios (adjPRRs) with 95% CIs. Adjusted models included participants' sex, age, community type, education, occupation and marital status. Among 1825 participants, 358 (19.6%) had a recent migration history. Overall, migrants exhibited a significantly higher combined prevalence of curable STIs (gonorrhoea, chlamydia, high-titre syphilis (rapid plasma regain ≥1:8) and trichomoniasis) as compared with long-term residents (34.4% vs 24.2%; adjPRR=1.23; 95% CI 1.03 to 1.47). Significant differences in curable STI prevalence by migration status were concentrated among persons living with HIV (49.4% prevalence in migrants vs 32.6% in long-term residents; adjPRR=1.42; 95% CI 1.10 to 1.85) and among women (38.8% in migrants vs 27.8% in long-term residents; adjPRR=1.26; 95% CI 1.01 to 1.58). High-titre syphilis prevalence was especially elevated among male migrants (11.2% in migrants vs 4.9% in long-term residents; adjPRR=1.82; 95% CI 1.06 to 3.13). The prevalence of non-HIV STIs is higher among migrants. Tailored outreach and service delivery approaches that address the needs of mobile populations are crucial for integrated HIV and STI epidemic control in Uganda to optimise resources and reduce transmission risks.

Identifiants

pubmed: 39134398
pii: sextrans-2024-056190
doi: 10.1136/sextrans-2024-056190
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: YCM has received grant support to Johns Hopkins University from Hologic, Cepheid, Roche, ChemBio, Becton Dickinson and miDiagnostics, and has provided consultative support to Abbot.

Auteurs

Michelle A Moffa (MA)

The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Xinyi Feng (X)

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Josephine Mpagazi (J)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Stephen Kiboneka (S)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Robert Ssekubugu (R)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

John Baptiste Kereba (JB)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Annet Nakayijja (A)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Julius Tukundane (J)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Jade Jackson (J)

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Caitlin E Kennedy (CE)

International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Godfrey Kigozi (G)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Ronald M Galiwango (RM)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Yukari C Manabe (YC)

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Charlotte A Gaydos (CA)

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Larry W Chang (LW)

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Sarah Kalibala (S)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Steven J Reynolds (SJ)

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Aaron Ar Tobian (AA)

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Thomas Quinn (T)

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

M Kate Grabowski (MK)

Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA mgrabow2@jhu.edu.
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Joseph Kagayi (J)

Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Department of Disease Control and Environmental Health, Makerere University, Kampala, Uganda.

Classifications MeSH